In addition, STAT3 signaling has been found to regulate both innate and adaptive immunity by increasing the expressions of growth factors and cytokines including TGF-β, VEGF, interleukin 6 (IL-6), and IL-10 [76–78], which collectively repress the host immune response and facilitate tumor immune evasion. The gene discussed is TGFB1; the disease is neoplasm.